Century Therapeutics Inc. (NASDAQ: IPSC) presented preclinical data for CNTY-813, its induced pluripotent stem cell-derived islet replacement therapy for type ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE